tiprankstipranks
Ocumension Therapeutics (HK:1477)
:1477
Hong Kong Market

Ocumension Therapeutics (1477) Financial Statements

Compare
1 Followers

Ocumension Therapeutics Financial Overview

Ocumension Therapeutics's market cap is currently HK$3.78B. The company's EPS TTM is HK$-0.525; its P/E ratio is ―; Ocumension Therapeutics is scheduled to report earnings on March 21, 2025, and the estimated EPS forecast is HK$-0.19. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue¥ 246.37M¥ 158.96M¥ 56.15M¥ 13.10M¥ 190.00K
Gross Profit¥ 144.37M¥ 102.92M¥ 36.94M¥ 11.37M¥ 180.00K
Operating Income¥ -402.15M¥ -397.23M¥ -385.20M¥ -2.27B¥ -1.34B
EBITDA¥ -320.62M¥ -359.98M¥ -371.30M¥ -2.26B¥ -1.32B
Net Income¥ -379.79M¥ -402.64M¥ -134.78M¥ -2.26B¥ -1.30B
Balance Sheet
Cash & Short-Term Investments¥ 1.05B¥ 1.29B¥ 1.77B¥ 2.03B¥ 1.25B
Total Assets¥ 3.27B¥ 3.04B¥ 3.33B¥ 2.60B¥ 1.29B
Total Debt¥ 137.98M¥ 29.58M¥ 11.21M¥ 7.24M¥ 1.26M
Net Debt¥ -704.86M¥ -1.14B¥ -1.11B¥ -2.03B¥ -191.15M
Total Liabilities¥ 351.03M¥ 295.04M¥ 222.88M¥ 97.23M¥ 3.36B
Stockholders' Equity¥ 2.92B¥ 2.75B¥ 3.11B¥ 2.50B¥ -2.07B
Cash Flow
Free Cash Flow¥ -539.79M¥ -510.66M¥ -861.66M¥ -517.18M¥ -108.85M
Operating Cash Flow¥ -177.93M¥ -200.66M¥ -196.85M¥ -212.57M¥ -108.09M
Investing Cash Flow¥ -259.78M¥ 229.15M¥ -1.35B¥ 629.70M¥ -979.92M
Financing Cash Flow¥ 108.66M¥ -9.22M¥ 668.85M¥ 1.53B¥ 1.24B
Currency in CNY

Ocumension Therapeutics Earnings and Revenue History

Ocumension Therapeutics Debt to Assets

Ocumension Therapeutics Cash Flow

Ocumension Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis